Skip to content

Inspire Medical Systems INSP Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

LivaNova logo
LivaNovaLIVN
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's accrued expenses and other liabilities?
Inspire Medical Systems (INSP) reported accrued expenses and other liabilities of -$12.32M in Q1 2026.
How has Inspire Medical Systems's accrued expenses and other liabilities changed year-over-year?
Inspire Medical Systems's accrued expenses and other liabilities increased by 24.5% year-over-year, from -$16.32M to -$12.32M.
What is the long-term trend for Inspire Medical Systems's accrued expenses and other liabilities?
Over 2 years (2021 to 2023), Inspire Medical Systems's accrued expenses and other liabilities has grown at a -1.1% compound annual growth rate (CAGR), from $7.06M to $6.9M.